In Brief: Medtronic Reveal
This article was originally published in The Gray Sheet
Executive Summary
Medtronic Reveal: Insertable loop recorder (ILR) launches in Europe and Canada for long-term monitoring and recording of electrical activity of the heart that may suggest cardiac arrhythmia. Placed in the chest region under a patient's skin, the 2.5 x 3/4 inch device features sensors that continuously record electrocardiogram signals. The system can be programmed to record and store up to 42 minutes of ECG data and lasts about 14 months, Medtronic says. Activation of an external, hand-held component preserves ECG data recorded during transient cardiac events. U.S. launch is slated for early 1998...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.